Glen H Barber

Title: Glen H Barber: Innovator in Anti-Tumor Assays

Introduction

Glen H Barber is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of cancer research, particularly through his innovative patent related to anti-tumor agents. His work focuses on the detection of neoplastic cells, which is crucial for early cancer diagnosis and treatment.

Latest Patents

Glen H Barber holds a patent titled "Anti-tumor agent assay using PKR." This patent describes a method for screening human tissue for the presence of neoplastic cells by determining the activity of PKR, P58 of anti-P58 in test cells being screened. The method identifies candidate neoplastic cells based on subnormal PKR, P58, or anti-P58 activity. The activities can be measured directly by assessing protein kinase activity or indirectly by detecting functional mutations in various proteins. Additionally, the patent discloses assay kits designed for carrying out this screening method. Glen H Barber has 1 patent to his name.

Career Highlights

Throughout his career, Glen H Barber has worked at prestigious institutions such as McGill University and the University of Washington. His research has significantly advanced the understanding of cancer biology and the development of diagnostic tools.

Collaborations

Glen H Barber has collaborated with esteemed colleagues, including Nahum Sonenberg and Michael G Katze. Their combined expertise has contributed to the advancement of research in the field of oncology.

Conclusion

Glen H Barber's innovative work in developing methods for detecting neoplastic cells has the potential to impact cancer diagnosis and treatment significantly. His contributions to the field are invaluable and highlight the importance of research in combating cancer.